|
|
|
|
| LEADER |
04801cam a2200625Ia 4500 |
| 001 |
ocn181341659 |
| 003 |
OCoLC |
| 005 |
20170124072007.6 |
| 006 |
m o d |
| 007 |
cr cn||||||||| |
| 008 |
071115s2003 enka ob 001 0 eng d |
| 040 |
|
|
|a DG1
|b eng
|c DG1
|d BTCTA
|d DG1
|d OCLCQ
|d OCLCF
|d OCLCA
|d NLGGC
|d YDXCP
|d OCLCQ
|d OCLCO
|d AU@
|d OCLCQ
|d DEBBG
|
| 019 |
|
|
|a 294883831
|a 842581820
|
| 020 |
|
|
|a 9780470987360
|
| 020 |
|
|
|a 0470987367
|
| 020 |
|
|
|a 9781405140157
|q (electronic bk.)
|
| 020 |
|
|
|a 1405140151
|q (electronic bk.)
|
| 020 |
|
|
|a 9780727914392
|
| 020 |
|
|
|a 0727914391
|
| 024 |
7 |
|
|a 10.1002/9780470987360
|2 doi
|
| 029 |
1 |
|
|a AU@
|b 000050961172
|
| 029 |
1 |
|
|a DEBBG
|b BV043386676
|
| 035 |
|
|
|a (OCoLC)181341659
|z (OCoLC)294883831
|z (OCoLC)842581820
|
| 037 |
|
|
|a 10.1002/9780470987360
|b Wiley InterScience
|n http://www3.interscience.wiley.com
|
| 050 |
1 |
4 |
|a RC254
|b .E95 2003eb
|
| 060 |
1 |
4 |
|a 2003 K-773
|
| 060 |
1 |
4 |
|a QZ 266
|b E93 2003
|
| 082 |
0 |
4 |
|a 616.992
|2 22
|
| 049 |
|
|
|a MAIN
|
| 245 |
0 |
0 |
|a Evidence-based oncology /
|c edited by Chris Williams ; associate editors, Vivien Bramwell [and others].
|
| 264 |
|
1 |
|a London :
|b BMJ Books,
|c 2003.
|
| 300 |
|
|
|a xvi, 618 pages :
|b illustrations ;
|c 28 cm +
|e 1 CD-ROM (4 3/4 in.)
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 504 |
|
|
|a Includes bibliographical references and index.
|
| 505 |
0 |
|
|a Ch. 1. Appraising clinical literature in cancer -- Ch. 2. Finding the "best evidence" for cancer care -- Ch. 3. Understanding the concepts behind health economics -- Ch. 4. Stringent application of epidemiological criteria changes the interpretation of the effects of immunotherapy in advanced renal cell cancer -- Ch. 5. Which interventions help individuals to stop smoking? -- Ch. 6. Breast cancer prevention trials -- Ch. 7. Is cancer risk reduced by a health-enhancing diet? -- Ch. 8. Is cancer risk reduced by the intake or supplementation of retinoids and carotenoids? -- Ch. 9. Do primary and secondary prevention interventions for sun protection reduce the risk of skin cancers? -- Ch. 10. Do sunscreens reduce the incidence skin cancers? -- Ch. 11. Can lifestyle behaviour change reduce the risk and incidence of urological cancers? -- Ch. 12. What is the role of prophylactic surgery in the prevention of colorectal cancer? -- Ch. 13. Screening for breast cancer -- Ch. 14. Cervical screening -- Ch. 15. Screening for prostate cancer -- Ch. 16. Screening for ovarian cancer -- Ch. 17. Screening for colorectal cancer -- Ch. 18. Screening for lung cancer -- Ch. 19. Screening for stomach cancer -- Ch. 20. Screening for melanoma -- Ch. 21. Lung cancer -- Ch. 22. Malignant pleural mesothelioma -- Ch. 23. Cancer of the oesophagus -- Ch. 24. Gastric carcinoma -- Ch. 25. Pancreatic cancer.
|
| 505 |
0 |
|
|a Ch. 26. Hepatobiliary cancers -- Ch. 27. The treatment of cancers of the small bowel -- Ch. 28. The treatment of carcinoma of the colon and rectum -- Ch. 29. Treatment of anal cancer -- Ch. 30. Kidney cancer -- Ch. 31. Cancer of the bladder -- Ch. 32. Cancer of the prostate -- Ch. 33. Cancer of the penis -- Ch. 34. Testicular germ cell cancer -- Ch. 35. Ovarian and fallopian tube cancers -- Ch. 36. Cancers of the uterine corpus -- Ch. 37. Cancer of the cervix and vagina -- Ch. 38. Treating vulval cancer -- Ch. 39. Gestational trophobastic disease -- Ch. 40. Breast cancer -- Ch. 41. Cutaneous melanoma -- Ch. 42. Treatment of basal cell carcinoma -- Ch. 43. Squamous cell carcinoma -- Ch. 44. Primary cutaneous T-cell lymphoma -- Ch. 45. Kaposi's sarcoma -- Ch. 46. Soft tissue sarcoma -- Ch. 47. Central nervous system tumours -- Ch. 48. Uveal melanoma -- Ch. 49. Ocular adnexal and orbital tumours.
|
| 533 |
|
|
|a Electronic reproduction.
|b Hoboken, N.J. :
|c Wiley InterScience,
|d 2007.
|n Mode of access: World Wide Web.
|n System requirements: Web browser.
|n Title from title screen (viewed on Nov. 14, 2007).
|n Access may be restricted to users at subscribing institutions.
|
| 650 |
|
0 |
|a Oncology.
|
| 650 |
|
0 |
|a Evidence-based medicine.
|
| 650 |
|
2 |
|a Neoplasms
|x therapy.
|
| 650 |
|
2 |
|a Evidence-Based Medicine.
|
| 650 |
|
2 |
|a Medical Oncology
|x methods.
|
| 650 |
|
7 |
|a Evidence-based medicine.
|2 fast
|0 (OCoLC)fst00917247
|
| 650 |
|
7 |
|a Oncology.
|2 fast
|0 (OCoLC)fst01045739
|
| 650 |
1 |
7 |
|a Kanker.
|2 gtt
|
| 650 |
1 |
7 |
|a Evidence-based practice.
|2 gtt
|
| 655 |
|
4 |
|a Electronic books.
|
| 700 |
1 |
|
|a Williams, C. J.
|q (Christopher John Hacon)
|
| 700 |
1 |
|
|a Bramwell, Vivien.
|
| 710 |
2 |
|
|a Wiley InterScience (Online service)
|
| 776 |
1 |
|
|c Original
|z 0727914391
|z 9780727914392
|w (OCoLC)52638564
|
| 856 |
4 |
0 |
|z View fulltext via EzAccess
|u https://ezaccess.library.uitm.edu.my/login?url=https://doi.org/10.1002/9780470987360
|
| 994 |
|
|
|a 92
|b DG1
|